Korean J Obstet Gynecol Search

CLOSE


Obstet Gynecol Sci > Volume 53(11); 2010 > Article
Korean Journal of Obstetrics & Gynecology 2010;53(11):961-966.
DOI: https://doi.org/10.5468/kjog.2010.53.11.961    Published online November 1, 2010.
Update on the management of pelvic inflammatory disease.
Moon Kyoung Cho
Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Korea. chomk@chonnam.ac.kr
Abstract
Pelvic inflammatory disease (PID), the infection and inflammation of a woman's upper genital tract, is a frequent cause of infertility, ectopic pregnancy, and chronic pelvic pain among women of childbearing age. The management of PID has been largely based on the protocols issued by national or international institution. These guidelines recommended a broad-spectrum antibiotherapy in which quinolones continue to hold a key place. Yet, several significant facts such as the increase of quinolone-resistant gonococci and the emergence of 'new' pathogens have recently led us to reconsider the paradigms of the management of PID. This article reviewed lately published literatures on new bacteriological finding and recent antibiotics trials to delinate optimal regimen in managing PID.
Key Words: Pelvic inflammatory disease, Antibiotics, Pathogen


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
POLICY
FOR CONTRIBUTORS
Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea
Tel: +82-2-3445-2382    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2021 by Korean Society of Obstetrics and Gynecology. All rights reserved.

Developed in M2PI

Close layer
prev next